Harrow Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. (HROW) on August 19, 2021. The company is incorporated in Delaware and operates as a healthcare technology firm. The report addresses a specific corporate governance event occurring on the date of the report.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is limited to reporting a change in corporate leadership.
Material Changes
The primary material change reported is a shift in the composition of the Board of Directors:
- Appointment: Mark L. Baum, the Company's Chief Executive Officer and existing Board member, was appointed as Chairman of the Board.
- Departure from Role: Dr. Robert J. Kammer stepped down as Chairman of the Board.
- Continued Service: Dr. Kammer remains a member of the Board of Directors.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, risks, contingencies, or unusual items. The report is strictly informational regarding the Board appointment.
Key Facts for Investor Verification
- Mark L. Baum now holds the dual role of CEO and Chairman of the Board.
- Dr. Robert J. Kammer retains his seat on the Board but no longer serves as Chairman.
- The change became effective on August 19, 2021.
- No financial performance data is disclosed in this specific filing.